Interestingly, ER, PR or Her2 negative breast cancer patients showed significantly reduced survival in CMTM4 high patients when compared to CMTM4 low patients (Appendix Fig. S3A, upper panel). The gene discussed is ERBB2; the disease is breast carcinoma.